as a result , famotidine should be considered the h2-receptor antagonist of choice for critically ill patients who require gastric-acid suppression and at the same time are being treated with other drugs that depend on the cytochrome p-450 mixed-function oxidase system for their metabolism and/or on renal tubular mechanisms for their excretion .
C0025519
metabolism
C0221102
excretion